HCA Healthcare (HCA)
(Delayed Data from NYSE)
$308.84 USD
-0.60 (-0.19%)
Updated May 2, 2024 04:00 PM ET
After-Market: $308.86 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Brokerage Reports
HCA Healthcare, Inc. [HCA]
Reports for Purchase
Showing records 161 - 180 ( 281 total )
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Volumes Slightly Weaker than Expected; Guidance Trimmed as Expected
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Trimming Estimates Slightly, but Value Proposition Remains
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Increasing EPS Estimates Slightly on Share Buyback and M-A Activity
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Postponed Vote on ACA Repeal Positive for Healthcare Providers.
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Healthcare: Draft Bill Indicates Direction GOP Considering for ACA Replacement
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J